Retention of ovaries and oxidative stress of surgery

International Journal of Gynecology and Obstetrics

Volumn 97, Issue 1, 2007, Pages 40-43

  Kaur, G ^a   Mishra, S ^a   Kaur, A ^a   Sehgal, A ^a   Nageswari, K S ^a   Prasad, R ^b  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Estrogen; ; Hysterectomy; ; Malondialdehyde; ; Oophorectomy; Reactive oxygen species; ; Reduced glutathione;

Indexed keywords

ESTROGEN; GLUTATHIONE; MALONALDEHYDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; EVALUATION; FEMALE; HUMAN; HYSTERECTOMY; MALE; MENOPAUSE; OVARIECTOMY; OVARY; OXIDATIVE STRESS; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY;

EID: 33847376029     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2006.11.022     Document Type: Article

References (27)

1. Speroff L., Glass R.H., and Nathan G.K. Menopause and Perimenopausal Transitions. Clinical Gynecology, Endocrinology and Infertility. 6th ed. (1999), Williams and Wilkins, Baltimore, MD, USA 643-724
2. Melton L.J., Khosla S., Malkesian G.D., Achenbach S.J., Oberg A.I., and Riggs B.L. Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res 18 (2003) 900-905
3. Huh K., Shin U.S., Choi J.W., and Lee S.I. Effect of sex hormone on lipid peroxidation in liver. Arch Pharm Res 17 (1994) 109-114
4. Gomez-Zubeldia M.A., Hernandez R., Viguera J., Arbues J.J., Aparicio A., and Millan J.C. Effect of bilateral ovariectomy and ovarian steroid hormones on the antioxidant system and plasma malondialdehyde levels in Wistar rats. Endocr Res 26 (2000) 97-107
5. Lacava Z.G.M., and Luna H. The anticlastogenic effect of tocopherol in peritoneal macrophages of benzinidozole-treated and ovariectomized mice. Mutat Res 305 (1994) 145-150
6. Persky A.M., Green P.S., Stubley L., Howell C.O., Zaulyanov L., Brazeau G.A., et al. Protective effect of estrogen against oxidative damage to heart and skeletal muscles in vivo and in vitro. Proc Soc Exp Biol Med 223 (2000) 59-66
7. Diaz-Flores M., Baiza-Gutman L.A., Pedron N.N., and Hicks J.J. Uterine glutathione reductase activity: modulation by estrogens and progesterone. Life Sci 65 (1999) 2481-2488
8. Parker W.H., Broader M.S., Liu Z., Shoupe D., Farquhar C., and Berek J.S. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 106 2 (2005) 219-226
9. Falkeborn M., Schairer G., Naessen T., and Perssonl. Risk of CHD. After oophorectomy and hysterectomy. J Clin Epidemiol 53 (2000) 832-837
10. Aggarwal N. Prophylactic oophorectomy. Indian Menopause Soc 7 2 (2006) 7-8
11. Bureau I., Anderson R.A., Arnoud J., Ray-Siguier Y., Favier A.E., and Roussel A.M. Trace mineral status in post menopausal women: impact of hormonal replacement therapy. J Trace Elem Med Biol 16 1 (2002) 9-13
12. Leal M., Diaz J., Serrano E., Abellan J., and Carbonel L.F. Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes. Obstet Gynecol 956 pt1 (2000) 804-809
13. Bednarek-Tupikowska G. Antioxidant properties of estrogen. Ginekol Pol 73 1 (2002) 61-67
14. Balkan J., Dogru-Abbasoglu S., Aykac-Toker G., and Uysal M. Serum pro-oxidant-antioxidant balance and low density lipoprotein oxidation in healthy subjects with different cholesterol levels. Clin Exp Med 3 4 (2004) 237-242
15. David F.A. Low dose hormone therapy for post menopausal women. Clin Obstet Gynecol 46 2 (2003) 317-324
16. Russow J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg G., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principle results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
17. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A., Black H., et al. The Women's Health Initiative Steering Committee: effect of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 (2004) 1701-1712
18. David D., Alderman E.L., Hsia J., Haward B.V., Lobb F.R., Rogers W.J., et al. Effect of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 288 (2002) 2432-2440
19. Keleman M., Vaidya D., Waters D.D., Howard B.V., Cobb F., Younes N., et al. Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a sub study of the Women's Angiographic Vitamin and Estrogen (WAVE) trial. Atherosclerosis 179 1 (2005) 193-200
20. American College of Obstetrician and Gynecologists. Clinical management guidelines for obstetrician-gynecologists. ACOG Practice Bulletin vol. 7 (1999), ACOG, Washington, DC
21. Armstrong K., Schwartz J., Randall T., Rubin S., and Weber B. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA 1/2 mutations-a decision analysis. J Clin Oncol 22 (2004) 1045-1054
22. Butler E., Durion O., and Kelly B. Improved method for the detection of blood glutathione. J Lab Clin Med 61 (1963) 882-883
23. Ohkawa H., Ohisi N., and Yagik. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 201 (1994) 508
24. Kumru S., Aydin S., Aras A., Gursu M.F., and Gulcu F. Effects of surgical menopause and ERT on Serum Paraoxonase activity and Plasma Malondialdehyde concentration. Gynecol Obstet Investig 59 (2005) 108-112
25. Verma S.D. Scientific basis for medical therapy of cataract by antioxidants. Am J Clin Nutr 53 (1991) 3355-3455
26. UF Researcher unravels Estrogen's antioxidant mechanism. http://www.napa.ufl.edu/2003news/estrogen.htm. (Sept.24,2003).
27. Bednarek-Tupikowska G. Antioxidant properties of estrogen. Ginekol Pol 73 1 (2002) 61-67